Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Biocept Inc (NQ: BIOC)
0.2790 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 7:55 PM EDT, Apr 7, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 0.2790
Bid (Size) 0.2620 (100)
Ask (Size) 0.2900 (10)
Prev. Close 0.2790
Today's Range 0.2790 - 0.2790
52wk Range 0.2100 - 2.110
Shares Outstanding 68,213,349
Dividend Yield N/A
Performance
YTD
-20.29%
-20.29%
1 Month
-36.59%
-36.59%
3 Month
-24.59%
-24.59%
6 Month
-65.12%
-65.12%
1 Year
-74.17%
-74.17%
Top News
More News
Australia Patent Issued for Primer-Switch Mutation Detection and Amplification Platform
Expands Biocept's intellectual property globally for methods of detecting rare mutations, including cancer biomarkers associated with circulating tumor DNA (ctDNA) Read More
from PR Newswire
Biocept Enters into Laboratory Services Agreement with Second California-Based Independent Physician Association
Contract with second IPA serving California expands patient access to Biocept's Target Selector™ liquid biopsy testing for the management of patients diagnosed with cancer Read More
from PR Newswire
More News
Read More
Biocept Reports 2019 Fourth Quarter and Full Year Financial Results
from PR Newswire
Biocept to Release 2019 Fourth Quarter and Full Year Financial Results and Host Investor Conference Call on March 25, 2020
from PR Newswire
Newly Published Data in Journal of Clinical Pathology Provides Clinical Validation for Biocept's Target Selector™ qPCR Assay to Identify Cancer-Associated Mutations
from PR Newswire
Thinking about buying stock in Biocept, Chembio Diagnostics, FuelCell Energy, General Motors, or Slack Technologies?
from PR Newswire
6 Stocks Moving In Wednesday's After-Hours Session
category NVUS , Movers , BIOC , and 9 more.
from Benzinga
90 Biggest Movers From Yesterday
category LADR , CNX , MITT , and 97 more.
from Benzinga
60 Stocks Moving In Thursday's Mid-Day Session
category SAR , BSGM , Market News , and 66 more.
from Benzinga
The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Xencor Licenses Tech To Vir For COVID-19 Treatment, Delay In Pfizer's Upjohn-Mylan Merger
category CERC , Earnings , Market News , and 34 more.
from Benzinga
17 Healthcare Stocks Moving In Thursday's Pre-Market Session
category HTBX , KTOV , TTOO , and 22 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.